Analysis of the contemporary use of high-dose chemotherapy (HDCT) in germ cell tumors (GCT) in Europe: Early findings of an ongoing EBMT-sponsored study

被引：0
|
作者：
Necchi, Andrea
Badoglio, Manuela
Miceli, Rosalba
Bourhis, Jean-Henri
Laszlo, Daniele
Nicolas-Virelizter, Emmanuelle
Wuchter, Patrick
Dreger, Peter
Kruger, William Hermann
Unal, Ali
Campos, Antonio
Montoro, Juan
Raggi, Daniele
Giannatempo, Patrizia
Gianni, Alessandro M.
Pedrazzoli, Paolo
Lanza, Francesco
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[2] EBMT Study Off, Paris, France
[3] Inst Gustave Roussy, Villejuif, France
[4] European Inst Oncol, Milan, Italy
[5] Ctr Leon Berard, F-69373 Lyon, France
[6] Univ Heidelberg Hosp, Dept Hematol Oncol & Rheumatol, Heidelberg, Germany
[7] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany
[8] Erciyes Univ, Kayseri, Turkey
[9] Portuguese Inst Oncol, Oporto, Portugal
[10] Univ Milan, Milan, Italy
[11] IRCCS San Matteo Univ Hosp Fdn, Med Oncol, Pavia, Italy
[12] Ist Ospitalieri Cremona, Cremona, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e15536
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15536
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Superior survival after sequential high-dose chemotherapy (HDCT) as compared to single HDCT in patients with relapsed or refractory germ cell tumors (GCT): Six-year long-term follow-up of a prospective, randomized phase II trial.
    Lorch, A.
    Kleinhans, A.
    Kramar, A.
    Hartmann, J. T.
    Bokemeyer, C.
    Rick, O.
    Beyer, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [42] Phase 2 trial of bevacizumab (BEV)/high-dose chemotherapy (HDC) with autologous stem-cell transplant (ASCT) for refractory germ-cell tumors (GCT).
    Nieto, Yago
    Tu, Shi-Ming
    Jones, Roy B.
    Tannir, Nizar M.
    Bassett, Roland L.
    Margolin, Kim Allyson
    Holmberg, Leona
    Champlin, Richard E.
    Pagliaro, Lance C.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [43] High-dose chemotherapy (HDCT) and peripheral-blood stem cell transplant (PBSCT) in patients age 40 or older with relapsed metastatic germ-cell tumors (mGCT).
    Agrawal, Vaibhav
    Althouse, Sandra K.
    Abonour, Rafat
    Abu Zaid, Mohammad Issam
    Sullivan, Cheryl K.
    Hanna, Nasser H.
    Einhorn, Lawrence H.
    Adra, Nabil
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [44] Can patients (pts.) with refractory germ cell tumors (GCT) be cured after progression following high dose chemotherapy (HDCT) with tandem transplant? Results with paclitaxel plus gemcitabine.
    Lewis, D. A.
    Brames, M. J.
    Einhorn, L. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 238S - 238S
  • [45] Second-line high-dose chemotherapy in patients with extragonadial nonseminomatous germ cell tumors: the experience of the European Group for Blood and Marrow Transplantation (EBMT)
    De Giorgi, Ugo
    Demirer, Taner
    Wandt, Hannes
    Taverna, Christian
    Siegert, Wolfgang
    Borhauser, Martin
    Kozak, Tomas
    Papiani, Giorgio
    Ballardini, Michela
    Rosti, Glovanni
    ANNALS OF ONCOLOGY, 2004, 15 : 121 - 121
  • [46] Standard-dose salvage chemotherapy in patients with refractory metastatic germ-cell tumors (mGCT) progressing after high-dose chemotherapy (HDCT) and peripheral-blood stem-cell transplant (PBSCT).
    Agrawal, Vaibhav
    Althouse, Sandra K.
    Hanna, Nasser H.
    Einhorn, Lawrence H.
    Adra, Nabil
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [47] Prognostic value of FDG-PET before high-dose (HD) chemotherapy (CTX) in metastatic germ-cell tumors (GCT): Correlation with CT and MRI
    Pfannenberg, AC
    Dohmen, BM
    Bokemeyer, C
    RADIOLOGY, 1998, 209P : 169 - 169
  • [48] Efficacy of epirubicin-paclitaxel (EPI-TAX) prior to high-dose chemotherapy (HDCT) in germ cell tumors (GCTs): A 17-year experience.
    Lotz, Jean-Pierre
    Soares, Daniele Grazziotin
    Culine, Stephane
    Laverdant, Benjamin
    Kieffer, Anne
    Dabi, Yohann
    Gligorov, Joseph
    Selle, Frederic
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [49] Chemotherapy for germ cell tumors relapsing after high-dose chemotherapy and stem cell support: A retrospective multicenter study of the Austrian Study Group on Urologic Oncology
    Pont, J
    Bokemeyer, C
    Harstrick, A
    Sellner, E
    Greinix, H
    Stoiber, F
    ANNALS OF ONCOLOGY, 1997, 8 (12) : 1229 - 1234
  • [50] Impact of body mass index (BMI) on clinical and toxicity outcomes in patients with relapsed metastatic germ-cell tumor (GCT) undergoing high-dose chemotherapy (HDCT) with peripheral blood stem cell transplant (PBSCT).
    Khalid, Ahmed Bilal
    Pham, Phillip
    Hassoun, Rebecca
    Althouse, Sandra K.
    Abonour, Rafat
    Abu Zaid, Mohammad Issam
    Hanna, Nasser H.
    Adra, Nabil
    Einhorn, Lawrence H.
    King, Jennifer
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 517 - 517
12345